Perry J J, Muss H B
Department of Internal Medicine, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, North Carolina.
Urol Clin North Am. 1994 Nov;21(4):661-72.
Advanced transitional cell carcinoma of the bladder is a chemotherapy-sensitive neoplasm. Several single agents demonstrate substantial activity, and combination chemotherapy produces responses in the majority of patients treated. The benefits and toxicities associated with the most widely used combination regimens are discussed. Other topics reviewed include the use of colony-stimulating factor support for chemotherapy, adjunctive surgical therapy, and newer cytotoxic regimens.
晚期膀胱移行细胞癌是一种对化疗敏感的肿瘤。几种单一药物显示出显著活性，联合化疗在大多数接受治疗的患者中产生反应。讨论了与最广泛使用的联合治疗方案相关的益处和毒性。回顾的其他主题包括使用集落刺激因子支持化疗、辅助手术治疗和更新的细胞毒性治疗方案。
